Early research (Phase 1)Study completedNCT06345404
What this trial is testing
Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD
Who this might be right for
Atopic Dermatitis
Corvus Pharmaceuticals, Inc. 82